Source: Υπουργείο Υγείας (CY) Revision Year: 2015 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Flutan 250mg tablets.
| Pharmaceutical Form |
|---|
|
Tablets. The tablets are light yellow, round, convex, scored tablets with 12 mm diameter. |
Each tablet contains 250mg of flutamide.
Excipient with known effect: lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Flutamide |
Flutamide is a non-steroidal, highly specific, orally active anti-androgenic agent. The pharmacologically active metabolite, hydroxyflutamide, is believed to exert an anti-androgenic effect directly on the target tissues, either by inhibiting androgen uptake or by blocking cytoplasmic and nuclear binding of androgen. Flutamide is indicated for the treatment of advanced prostatic carcinoma in which suppression of testosterone effects is indicated. |
| List of Excipients |
|---|
|
Croscarmellose sodium |
The tablets are packed in aluminium foil and polyvinylchloride blisters with a patient information leaflet, in a card carton. Packs containing 20 and 100 tablets are available. Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
13410
25.06.1991 / 30.07.2013
| Drug | Countries | |
|---|---|---|
| FLUTAN | Cyprus, Hong Kong, Malta, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
